A Study to Evaluate CM336 in Adults with Autoimmune Bullous Disease

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

January 1, 2026

Study Completion Date

January 1, 2027

Conditions

Autoimmune Bullous Disease

Interventions

BIOLOGICAL

CM336 Injection

subcutaneous CM336 administration

Trial Locations (1)

RECRUITING

Dermatology Hospital Affiliated to Shandong First Medical University, Jinan

All Listed Sponsors

lead

Shandong First Medical University

OTHER